Stammdaten
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
Unternehmen & Branche
| Name | Protagenic Therapeutics, Inc.\new |
|---|---|
| Ticker | PTIX |
| CIK | 0001022899 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,9 Mio. USD |
| Beta | 0,47 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 0 | 2,210,769 | 1.14 | 4,431,101 | -2,392,688 |
| 2025-09-30 | 10-Q | 0 | -869,496 | -0.47 | 5,002,847 | -4,700,565 |
| 2025-06-30 | 10-Q | -5,057,523 | -3,974,011 | |||
| 2025-03-31 | 10-Q | 0 | -1,440,005 | -2.75 | 89,093 | -4,952,959 |
| 2024-12-31 | 10-Q | -850,287 | -0.16 | 1,955,913 | -3,318,122 | |
| 2024-12-31 | 10-K | 0 | -5,525,344 | -1.13 | 1,955,913 | 1,013,154 |
| 2024-09-30 | 10-Q | 0 | -582,387 | -0.11 | 1,508,327 | -2,470,581 |
| 2024-06-30 | 10-Q | 0 | -324,355 | -0.36 | 1,467,077 | -1,753,190 |
| 2024-03-31 | 10-Q | 0 | -1,724,294 | -5.44 | 2,578,558 | -1,789,166 |
| 2023-12-31 | 10-K | 0 | -5,000,497 | -1.15 | 4,323,369 | 3,668,117 |
| 2023-09-30 | 10-Q | 0 | -1,396,626 | -0.32 | 5,432,642 | 4,152,536 |
| 2023-06-30 | 10-Q | 0 | -1,209,591 | -0.28 | 6,919,121 | 5,413,731 |
| 2023-03-31 | 10-Q | 0 | -718,096 | -0.17 | 7,666,288 | 6,414,313 |
| 2022-12-31 | 10-K | 0 | -3,555,505 | -0.82 | 8,037,420 | 6,917,558 |
| 2022-09-30 | 10-Q | 0 | -925,305 | -0.21 | 8,254,296 | 7,382,040 |
| 2022-06-30 | 10-Q | 0 | -666,717 | -0.15 | 9,014,508 | 8,258,098 |
| 2022-03-31 | 10-Q | 0 | -1,362,109 | 9,798,288 | 8,719,583 | |
| 2021-12-31 | 10-K | 0 | -4,522,934 | 11,059,923 | 9,941,955 | |
| 2021-09-30 | 10-Q | 0 | -878,299 | 11,657,105 | -10,370,599 | |
| 2021-06-30 | 10-Q | 0 | -1,547,796 | 12,062,140 | 10,798,138 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.